- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Adjuvant Chemotherapy In Completely Resected Non- Small- Cell Lung Cancer ; volume:25 ; number:02 ; year:2004 ; pages:32-33
Indian journal of medical & paediatric oncology ; 25, Heft 02 (2004), 32-33
- Contributor
-
Khattry, N.
Sharma, A.
- DOI
-
10.1055/s-0041-1733072
- URN
-
urn:nbn:de:101:1-2022051211065946211137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khattry, N.
- Sharma, A.
Other Objects (12)
Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases